未登录

S

Se Jin Oh

Korea University College of Medicine

H指数:17

被引数:823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The E2F1-HMGCR axis promotes ferroptosis resistance in immune refractory tumor cells

E2F1-HMGCR轴促进免疫抵抗性肿瘤细胞中的铁死亡抗性。

Nature Communications

IF15.7

2025-12-030

OAAI

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway

NATURE COMMUNICATIONS

IF15.7

2023-05-1018

OAAI

NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59

SCIENTIFIC REPORTS

IF3.9

2022-05-236

OAAI

Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes

NATURE COMMUNICATIONS

IF15.7

2022-04-197

OAAI

Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2022-03-1512

OAAI

Human Ferritin Platform and Its Optimized Structures to Enhance Anti-Cancer Immunity

ADVANCED THERAPEUTICS

IF2.6

2020-12-219

OAAI

NANOG-HSP90A axis confers immunotherapeutic resistance by blocking anti-tumor immunity cycle

CANCER RESEARCH

IF16.6

2020-08-150

PRE

LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells

IF14.3

2020-08-1426

OAAI

Regulation of mRNA export through API5 and nuclear FGF2 interaction

NUCLEIC ACIDS RESEARCH

IF13.1

2020-05-0829

OAAI

HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors

NATURE COMMUNICATIONS

IF15.7

2020-01-2861

OAAI

Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2018-08-2035

OA

Blockade of cyclin D-CDK4/6 sensitizes immune-refractory tumor cells to tumor antigen-specific T cell-mediated cytotoxicity by repressing SCP3-NANOG axis

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis

CANCER RESEARCH

IF16.6

2018-05-1434

OAAI

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells

CANCER RESEARCH

IF16.6

2017-09-1468

OAAI

API5 induces cisplatin resistance through FGFR signaling in human cancer cells

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2017-09-0822

OAAI

API5 confers cancer stem cell-like properties through the FGF2-NANOG axis

IF6.4

2017-01-1627

OAAI

REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival

CELL DEATH & DISEASE

IF9.6

2017-01-0519

OAAI

Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy

SCIENTIFIC REPORTS

IF3.9

2016-10-1186

OAAI

NANOG signaling promotes metastatic capability of immunoedited tumor cells

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2015-04-2215

PREAI